WuXi clinched a deal with the Worcester Business Development Corporation to build its first U.S. biologics facility at a 46-acre master-planned manufacturing hub dubbed The Reactory. The two-story, 107,000-square-foot facility will cost $60 million and employ 150 when it is fully operational in 2022, WuXi said in a release.

According to the Worcester Telegram & Gazette, the Worcester City Council in January inked a 20-year, $11.5 million tax increment financing plan to coax WuXi, which will be the first occupant at The Reactory. Source: Fierce Pharma 19/5/2020